Co-director Professor Jonas Larsson From January 2020 we warmly welcome professor Jonas Larsson as new Co-director! Jonas Larsson is Professor in Hematology and also bring long-term experience to WCMM LU as Director for StemTherapy – a National Initiative on Stem Cells for Regenerative Therapy. Please, read more about Professor Larsson research at Lund university reasearch portal, Lucris

https://www.wcmm.lu.se/article/wcmm-lu-welcomes-new-co-director-professor-jonas-larsson-january-2020 - 2025-08-27

At WCMM LU we believe in educating and supporting our PIs in professional development and academic leadership. All recruited PIs are welcomed to a mentor program, where they are matched with a mentor (a senior Professor at ot faculty) and invited to professional lead seminars in collaboration with INDEA AB and their senior consultant and psychologist Katarina Billing. February 11 we celebrated the

https://www.wcmm.lu.se/article/celebration-second-round-wcmm-lu-mentor-program-february-11-2020 - 2025-08-27

Excellent example on successful Translational Research at WCMM Lund between Anja Meissner and Martin Magnusson: - Phospholipid S1P suggested as a potential biomarker in cardiovascular disease Anja Meissner Martin Magnusson In 2017 both Anja Meissner and Martin Magnusson were recruited to WCMM Lund, as WCMM Fellow and WCMM Clinical Researcher, respectively. Using a translation approach including a

https://www.wcmm.lu.se/article/successful-translational-research-between-two-researchers-wcmm-lund - 2025-08-27

The Swedish Medical Society's Translational Prize 2021 is awarded to Andreas Edsfeldt, researcher and associate professor at the Department of Clinical Sciences, Lund University, and a doctor at the Heart Care Section, Skåne University Hospital Malmö. Andreas Edsfeldt is rewarded for his application "Apoptosis and efferocytosis as mechanism of impaired fibrotic tissue repair in diabetes associated

https://www.wcmm.lu.se/article/andreas-edsfeldt-receives-translational-award-studies-diabetes-and-risk-cardiovascular-diseases - 2025-08-27

WCMM Research School is one of the most important pieces of regenerative medicine training we provide here as a centre. This year we will have have 18 students, ranging from 1st year PhD students to senior post-docs from different faculties, including LTH, Biology, Clinicians and the Faculty of Medicine. This inter-disciplinary cross-faculty student cohort really underscores the bright future for

https://www.wcmm.lu.se/article/kick-wcmm-research-school-2021-2022 - 2025-08-27

We are delighted to host Dr. Alejo Rodriguez Fraticelli from IRB Barcelona. Since 2021, he heads the Lab of Quantitative Stem Cell Dynamics at IRB Barcelona where his  group focuses on understanding the mechanisms that regulate blood stem cell heterogeneity and how they play a role in homeostasis, immunity and disease.  The title of his talk is: ”Finding the pattern: from epithelia to hematopoesis

https://www.wcmm.lu.se/article/wcmm-research-school-external-speaker-seminar - 2025-08-27

Filipe Pereira. Photo: Kennet Ruona Asgard Therapeutics AB, a private biotech company which originate from Lund University’s Cell Reprogramming and Immunity lab, led by the WCMM Fellow Professor Filipe Pereira, has announced the completion of a EUR 6 million seed financing round. The financing was co-led by Novo Holdings, Boehringer Ingelheim Venture Fund and Industrifonden. Filipe Pereira is Asga

https://www.wcmm.lu.se/article/asgard-therapeutics-raises-eur-6m-seed-financing-exploit-direct-vivo-reprogramming - 2025-08-27

As part of a larger study, a first successful operation using 3D printed cranioplasty implant has been done at Skåne university hospital. The Wallenberg Molecular Medicine Clinical Researcher Einar Heiberg is one of the clinicians behind the new method where imaging and image processing are used to develop patient specific 3D-printed skull implants. In an ongoing translational project, the first 3

https://www.wcmm.lu.se/article/patient-specific-3d-printed-skull-implants - 2025-08-27

The WCMM researcher Joao Duarte and his team strive to understand how a diet rich on fat and sugar impacts memory functions in relation to obesity and type 2 diabetes. Their new study on mice shows that although an unhealthy diet leads to memory impairment, the damage does not have to be permanent. The WCMM researcher Joao Duarte was recently in focus when Lund University Diabetes Centre, LUDC, pu

https://www.wcmm.lu.se/article/does-food-we-eat-have-impact-our-brain - 2025-08-27

Wallenberg Molecular Medicine Clinical Researcher - Sandra Lindstedt The focus of cardiothoracic surgeon Sandra Lindstedt and her research team is lung transplantation. “Today, we can only use 20 percent of the donor lungs. What if we could recondition and regain lung function of just a portion of those lungs that we cannot use today? That would have a huge impact for patients on the waiting list

https://www.wcmm.lu.se/article/my-vision-no-patients-should-die-waiting-organ-transplant - 2025-08-27

Wallenberg Molecular Medicine Clinical Researcher - Karin Tran Lundmark Paediatric cardiologist Karin Tran Lundmark treats patients with pulmonary hypertension, a condition that means high blood pressure in the lung. Karin Tran Lundmark’s research is focused on finding ways to treat what is causing the high blood pressure. “Currently, we can reduce symptoms and prolong survival, but there is no cu

https://www.wcmm.lu.se/article/i-hope-i-will-be-able-tell-my-patients-we-have-curative-therapy - 2025-08-27

Wallenberg Molecular Medicine Clinical Researcher - Andreas Edsfeldt Cardiologist Andreas Edsfeldt’s focus in research is to understand the underlying biology in type 2 diabetes associated with certain complications, such as myocardial infarction and stroke. “Cardiovascular complications are much more common among individuals with type 2 diabetes. What if we could identify new therapies to reduce

https://www.wcmm.lu.se/article/understanding-more-we-can-identify-new-therapies-complications-due-type-2-diabetes - 2025-08-27

Wallenberg Molecular Medicine Clinical Researcher - Robin Kahn Rheumatologist Robin Kahn’s focus in research is children with juvenile idiopathic arthritis. Together with his research team, he is trying to find the answers to two questions: why certain children get this condition – and how can it be cured. “These two questions actually triggered me, and an entire team, to start doing research.” Ro

https://www.wcmm.lu.se/article/children-always-ask-why-did-i-get - 2025-08-27

Wallenberg Molecular Medicine Clinical Researcher - Lisa Påhlman Lisa Påhlman, a specialist in infectious diseases, has a main research focus on airway infections in cystic fibrosis – a genetic disease that affects many organs of the body, perhaps most importantly the lungs. “If we knew more about the bacteria and fungi that these patients are colonised with, we could hopefully have a more tailore

https://www.wcmm.lu.se/article/i-hope-my-research-will-lead-more-knowledge-about-bacteria-cystic-fibrosis - 2025-08-27

Wallenberg Molecular Medicine Clinical Researcher - Einar Heiberg The focus of medical engineer Einar Heiberg’s research is on empowering physicians with patient-specific 3D models to help each patient. “The vision that I have is that for complex surgeries, the surgeons have already done the surgery multiple times and know exactly what to expect.” Einar Heiberg is a medical engineer at the Centre

https://www.wcmm.lu.se/article/already-now-we-are-producing-patient-specific-implants-shorten-surgical-time - 2025-08-27

Wallenberg Molecular Medicine Clinical Researcher - Gesine Paul-Visse Neurologist Gesine Paul-Visse's research focus is on discovering, developing and implementing new therapies for neurological diseases such as Parkinson’s disease and stroke. “I am motivated every day by the need of the patients I meet in my clinical practice.” Gesine Paul-Visse is a senior consultant in neurology at Skåne Univer

https://www.wcmm.lu.se/article/we-hope-find-neuroprotective-treatment-can-slow-down-disease-progression - 2025-08-27

Wallenberg Molecular Medicine Clinical Researcher - Martin Magnusson The focus of cardiologist Martin Magnusson’s research is epidemiological clinical heart failure as well as diabetes and cardiovascular studies. “We use large population-based and patient-based cohorts to investigate biomarkers and their association with disease. It all aims to find new drug targets for diabetes and cardiovascular

https://www.wcmm.lu.se/article/its-every-researchers-dream-find-new-treatments-diseases - 2025-08-27

Wallenberg Molecular Medicine Clinical Researcher - Anders Wittrup The focus of oncologist Anders Wittrup’s research is so called RNA therapeutics and how it can be developed into cancer therapies. “We have a special focus on brain cancers for which there today are very poor treatment options.” Anders Wittrup is a resident in oncology at Skåne University Hospital and a researcher at Wallenberg Cen

https://www.wcmm.lu.se/article/need-better-therapeutic-options-brain-cancers-very-big - 2025-08-27

Wallenberg Molecular Medicine Clinical Researcher - Elin Trägårdh The focus of senior consultant Elin Trägårdh’s research is diagnostic nuclear medicine – in particular a modality called PET/CT. It is used mainly for evaluation of patients with cancer. Today, PET/CT is reviewed manually by doctors. ”I think we don't use all the information there is in the images. What if we could use artificial in

https://www.wcmm.lu.se/article/i-believe-validated-pet-imaging-biomarkers-could-transform-future-clinical-cancer-care - 2025-08-27

Wallenberg Molecular Medicine Clinical Researcher - Kees-Jan Pronk The focus of paediatric oncologist Kees-Jan Pronk’s research is to find out what happens with the blood system in children that develop leukaemia. The other focus of his research is to reduce side effects of leukaemia treatments. “We are trying to find ways to reduce the side effects, but still keeping the treatment as effective as

https://www.wcmm.lu.se/article/i-would-come-point-where-we-cure-even-more-children-are-diagnosed-leukaemia - 2025-08-27